These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23297096)

  • 21. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics.
    Duce JA; Bush AI
    Prog Neurobiol; 2010 Sep; 92(1):1-18. PubMed ID: 20444428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases.
    Lin JZ; Duan MR; Lin N; Zhao WJ
    Rev Neurosci; 2021 Nov; 32(7):737-750. PubMed ID: 33655733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system.
    Haylock-Jacobs S; Keough MB; Lau L; Yong VW
    Autoimmun Rev; 2011 Oct; 10(12):766-72. PubMed ID: 21664302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
    Multhaup G; Mechler H; Masters CL
    J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nervous system proteoglycans as modulators of neurite outgrowth.
    Bovolenta P; Fernaud-Espinosa I
    Prog Neurobiol; 2000 Jun; 61(2):113-32. PubMed ID: 10704995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective Properties of Neural Extracellular Matrix.
    Suttkus A; Morawski M; Arendt T
    Mol Neurobiol; 2016 Jan; 53(1):73-82. PubMed ID: 25404091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology.
    Viapiano MS; Matthews RT
    Trends Mol Med; 2006 Oct; 12(10):488-96. PubMed ID: 16962376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proteoglycans and neural circuit reconstruction].
    Kadomatsu K
    Seikagaku; 2011 Mar; 83(3):240-6. PubMed ID: 21516691
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse.
    Costa C; Tortosa R; Domènech A; Vidal E; Pumarola M; Bassols A
    J Chem Neuroanat; 2007 May; 33(3):111-23. PubMed ID: 17349777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of heparan sulfate in the generation of Abeta.
    Patey SJ
    Drug News Perspect; 2006 Sep; 19(7):411-6. PubMed ID: 17080204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer.
    Silver DJ; Silver J
    Curr Opin Neurobiol; 2014 Aug; 27():171-8. PubMed ID: 24762654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease therapeutics: new approaches to an ageing problem.
    Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
    IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitory proteins of neuritic regeneration in the extracellular matrix: structure, molecular interactions and their functions. Mechanisms of extracellular balance].
    Vargas J; Uribe-Escamilla R; Alfaro-Rodríguez A
    Rev Invest Clin; 2013; 65(4):336-48. PubMed ID: 24304735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway.
    Randall AD; Witton J; Booth C; Hynes-Allen A; Brown JT
    Neuropharmacology; 2010; 59(4-5):243-67. PubMed ID: 20167227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "GAG-ing with the neuron": The role of glycosaminoglycan patterning in the central nervous system.
    Smith PD; Coulson-Thomas VJ; Foscarin S; Kwok JC; Fawcett JW
    Exp Neurol; 2015 Dec; 274(Pt B):100-14. PubMed ID: 26277685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular matrix and perineuronal nets in CNS repair.
    Kwok JC; Dick G; Wang D; Fawcett JW
    Dev Neurobiol; 2011 Nov; 71(11):1073-89. PubMed ID: 21898855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.